Premium
Combination therapy of apremilast and secukinumab in patients with moderate‐to‐severe, recalcitrant plaque psoriasis
Author(s) -
Sacchelli L.,
Patrizi A.,
Loi C.,
Bardazzi F.
Publication year - 2019
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.14000
Subject(s) - secukinumab , apremilast , plaque psoriasis , medicine , dermatology , psoriasis , psoriatic arthritis